menu
    • menu

    Company profile for Catalent Pharma Solutions

    NEW Drugs in Dev.: 34
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a global leader in providing integrated services, superior drug delivery technologies & manufacturing solutions to help life science innovators develop & launch successful pharmaceuticals, biologics and consumer health products, enabling a better customer journey from product development to patient. With over 85 years of experience in the industry, Catalent supports partners in introducing 200 new products and manufactu...
    We are a global leader in providing integrated services, superior drug delivery technologies & manufacturing solutions to help life science innovators develop & launch successful pharmaceuticals, biologics and consumer health products, enabling a better customer journey from product development to patient. With over 85 years of experience in the industry, Catalent supports partners in introducing 200 new products and manufacturing over 70 billion doses/year. We have grown to become a vibrant community of approximately 15,000 employees, including around 2,400 scientists and technicians, supporting over 7,000 products for over 1,000 customers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Catalent Pharma SolutionsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    14 Schoolhouse Road, Somerset, NJ 08873
    Telephone
    Telephone
    +1 877-587-1835
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.catalent.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/catalent-pharma-solutions/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/catalentpharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA hit Catalent's Maryland Manufacturing Sites with Form 483
    FDA hit Catalent's Maryland Manufacturing Sites with Form 483

    19 Dec 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/fda-outlined-concerns-elevidys-manufacturing-catalents-maryland-manufacturing-sites

    FIERCE PHARMA
    19 Dec 2025
    Share Share
    Novo Gets Warning Letter At Site Formerly Owned By Catalent
    Novo Gets Warning Letter At Site Formerly Owned By Catalent

    17 Dec 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/novo-gets-fda-warning-letter-troubled-indiana-site-formerly-owned-catalent

    FIERCE PHARMA
    17 Dec 2025
    Share Share
    Biotechs Secure Fill/Finish Capacity Amid Novo Site Scrutiny
    Biotechs Secure Fill/Finish Capacity Amid Novo Site Scrutiny

    02 Dec 2025

    // BIOSPACE

    https://www.biospace.com/business/biotechs-secure-alternative-fill-finish-capacity-amid-scrutiny-of-novo-site

    BIOSPACE
    02 Dec 2025
    Share Share
    Catalent Showcases Smartag ADC Pipeline At World ADC San Diego
    Catalent Showcases Smartag ADC Pipeline At World ADC San Diego

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251104076968/en/Catalents-SMARTag-ADC-Pipeline-and-New-Enhanced-Conjugates-Offering-Featured-at-16th-World-ADC-San-Diego

    BUSINESSWIRE
    04 Nov 2025
    Share Share
    Lisata Therapeutics Showcases Certepetide Preclinical Data
    Lisata Therapeutics Showcases Certepetide Preclinical Data

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180798/18623/en/Lisata-Therapeutics-Highlights-Positive-Preclinical-Data-of-Certepetide-as-Part-of-Antibody-Drug-Conjugate-Combinations-as-Reported-by-Licensing-Partner-Catalent.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    Catalent Unveils New Brand Focused on Customer Mission Excellence
    Catalent Unveils New Brand Focused on Customer Mission Excellence

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251027751926/en/Catalent-Debuts-New-Corporate-Brand-Elevating-Customer-Service-Excellence-by-Championing-the-Missions-that-Matter

    BUSINESSWIRE
    28 Oct 2025
    Share Share

    USDMF

    read-more
    read-more

    01

    Accutane (10mg, 40mg)

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    02

    Advil Cold And Sinus Liquid Gels

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    03

    Advil Liqui-gels, 200 Mg

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    04

    Advil Pm Liqui-gels

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    05

    Amprenavir 50 And 150 Mg Soft Gelati...

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    06

    Amr101 1g Capsules

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    07

    Atrasentan Hydrochloride, Soft Gelat...

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    08

    Calcitriol 0.25 Mcg Soft Gelatin Cap...

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    09

    Calderol Softgels 20mcg

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    10

    Drisdol Softgels (ergocalciferol, 50...

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    JDMF

    read-more
    read-more

    01

    Borhyaluronidase alpha (genetical recomb...

    JDMF

    BIO Partnering at JPM
    Not Confirmed
    arrow

    Borhyaluronidase alpha (genetical recomb...

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Catalent Pharma Solutions

    Registration Number : 302MF10030

    Registrant's Address : 1300 South Patterson Drive, Bloomington, Indiana 47403 USA

    Initial Date of Registration : 2020-02-20

    Latest Date of Registration : 2025-03-26

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Netarsudil Mesylate

    JDMF

    BIO Partnering at JPM
    Not Confirmed
    arrow

    Netarsudil Mesylate

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Catalent Pharma Solutions

    Registration Number : 307MF10071

    Registrant's Address : 1180 E. Ellsworth Rd, Ann Arbor, MI 48108, USA

    Initial Date of Registration : 2025-06-18

    Latest Date of Registration : 2025-06-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lisata Therapeutics and Catalent Announce Global ]ADC License Agreement

    Details:

    Through the licensing deal, an undisclosed antibody-drug conjugate for cancer is being advanced.


    Lead Product(s): Undisclosed

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: DiscoveryProduct Type: Antibody-drug Conjugate

    Recipient: Lisata Therapeutics

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Licensing Agreement October 08, 2025

    blank

    01

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Oncology

    Highest Development Status : Discovery

    Recipient : Lisata Therapeutics

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    Lisata Therapeutics and Catalent Announce Global ]ADC License Agreement

    Details : Through the licensing deal, an undisclosed antibody-drug conjugate for cancer is being advanced.

    Product Name : Undisclosed

    Product Type : Antibody-drug Conjugate

    Upfront Cash : Undisclosed

    October 08, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    GenSight Biologics Announces Milestone in Manufacturing Partnership with Catalent

    Details:

    The upstream phase of the manufacturing process for Lumevoq, the Company’s gene therapy candidate for the rare mitochondrial disease LHON, has been successfully transferred to Catalent.


    Lead Product(s): Lenadogene Nolparvovec

    Therapeutic Area: Ophthalmology Brand Name: Lumevoq

    Study Phase: Phase IIIProduct Type: Cell & Gene Therapy

    Sponsor: GenSight Biologics

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership June 26, 2025

    blank

    02

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Lenadogene Nolparvovec

    Therapeutic Area : Ophthalmology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : GenSight Biologics

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    GenSight Biologics Announces Milestone in Manufacturing Partnership with Catalent

    Details : The upstream phase of the manufacturing process for Lumevoq, the Company’s gene therapy candidate for the rare mitochondrial disease LHON, has been successfully transferred to Catalent.

    Product Name : Lumevoq

    Product Type : Cell & Gene Therapy

    Upfront Cash : Undisclosed

    June 26, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Silexion Partners with Catalent on Advanced siRNA Development

    Details:

    The collaboration aims to advnace the clinical development of Silexion's SIL-204, which is a next-generation siRNA candidate. It is being evaluated for KRAS-mutated cancers.


    Lead Product(s): SIL-204

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: PreclinicalProduct Type: Oligonucleotide

    Sponsor: Silexion Therapeutics

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Collaboration April 23, 2025

    blank

    03

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : SIL-204

    Therapeutic Area : Oncology

    Highest Development Status : Preclinical

    Partner/Sponsor/Collaborator : Silexion Therapeutics

    Deal Size : Undisclosed

    Deal Type : Collaboration

    DEALS_DEV arrow-down

    Silexion Partners with Catalent on Advanced siRNA Development

    Details : The collaboration aims to advnace the clinical development of Silexion's SIL-204, which is a next-generation siRNA candidate. It is being evaluated for KRAS-mutated cancers.

    Product Name : Undisclosed

    Product Type : Oligonucleotide

    Upfront Cash : Undisclosed

    April 23, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lisata Therapeutics Announces Research License with Catalent

    Details:

    Lisata and Catalent will evaluate the combination of certepetide and the SMARTag ADC platform, dual-payload technology platform for the treatment of advanced solid tumors.


    Lead Product(s): Undisclosed

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: PreclinicalProduct Type: Undisclosed

    Recipient: Lisata Therapeutics

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement April 15, 2025

    blank

    04

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Oncology

    Highest Development Status : Preclinical

    Recipient : Lisata Therapeutics

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Lisata Therapeutics Announces Research License with Catalent

    Details : Lisata and Catalent will evaluate the combination of certepetide and the SMARTag ADC platform, dual-payload technology platform for the treatment of advanced solid tumors.

    Product Name : Undisclosed

    Product Type : Undisclosed

    Upfront Cash : Undisclosed

    April 15, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Jupiter, Catalent Sign JOTROL Manufacturing Deal for Parkinson’s Phase 2a

    Details:

    Under the agreement, Catalent Pharma will be responsible for the production of Jotrol (resveratrol) softgel capsules to support Jupiter’s upcoming Phase 2a clinical trial in Parkinson’s disease.


    Lead Product(s): Resveratrol

    Therapeutic Area: Neurology Brand Name: Jotrol

    Study Phase: Phase IProduct Type: Plant Extract/Herbal

    Sponsor: Jupiter Neurosciences

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement February 03, 2025

    blank

    05

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Resveratrol

    Therapeutic Area : Neurology

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Jupiter Neurosciences

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Jupiter, Catalent Sign JOTROL Manufacturing Deal for Parkinson’s Phase 2a

    Details : Under the agreement, Catalent Pharma will be responsible for the production of Jotrol (resveratrol) softgel capsules to support Jupiter’s upcoming Phase 2a clinical trial in Parkinson’s disease.

    Product Name : Jotrol

    Product Type : Plant Extract/Herbal

    Upfront Cash : Undisclosed

    February 03, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Siren Biotechnology and Catalent Partner to Manufacture AAV Gene Therapies for Cancer

    Details:

    The partnership aims to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies, being developed for the treatment of cancer.


    Lead Product(s): Undisclosed

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: PreclinicalProduct Type: Undisclosed

    Sponsor: Siren Biotechnology

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership May 08, 2024

    blank

    06

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Oncology

    Highest Development Status : Preclinical

    Partner/Sponsor/Collaborator : Siren Biotechnology

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    Siren Biotechnology and Catalent Partner to Manufacture AAV Gene Therapies for Cancer

    Details : The partnership aims to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies, being developed for the treatment of cancer.

    Product Name : Undisclosed

    Product Type : Undisclosed

    Upfront Cash : Undisclosed

    May 08, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for its Zydis® Fast-Dissolve Technology for Use in MELT-300 fo...

    Details:

    Under the agreement, Melt Pharmaceuticals will utilize Catalent’s proprietary Zydis® orally disintegrating tablet fast-dissolve technology with MELT-300 (midazolam), a sublingual, needle- and opioid-free patented formulation for procedural sedation during cataract surgery.


    Lead Product(s): Midazolam,Ketamine Hydrochloride

    Therapeutic Area: Neurology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Controlled Substance

    Sponsor: Melt Pharmaceuticals

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Licensing Agreement September 26, 2023

    blank

    07

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Midazolam,Ketamine Hydrochloride

    Therapeutic Area : Neurology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Melt Pharmaceuticals

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for its Z...

    Details : Under the agreement, Melt Pharmaceuticals will utilize Catalent’s proprietary Zydis® orally disintegrating tablet fast-dissolve technology with MELT-300 (midazolam), a sublingual, needle- and opioid-free patented formulation for procedural sedation du...

    Product Name : Undisclosed

    Product Type : Controlled Substance

    Upfront Cash : Undisclosed

    September 26, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MindMed Announces Exclusive License Agreement with Catalent for its Patented Zydis® Fast-Dissolve Technology for Use with MM-120

    Details:

    Under the agreement, Catalent has granted MindMed access to its Zydis technology for the development of MindMed’s lead candidate MM-120 (lysergide D-tartrate), which is currently in Phase 2 for generalized anxiety disorder.


    Lead Product(s): Lysergide D-tartrate

    Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Controlled Substance

    Sponsor: Mind Medicine

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Licensing Agreement August 03, 2023

    blank

    08

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Lysergide D-tartrate

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Mind Medicine

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    MindMed Announces Exclusive License Agreement with Catalent for its Patented Zydis® Fast-Dissolve...

    Details : Under the agreement, Catalent has granted MindMed access to its Zydis technology for the development of MindMed’s lead candidate MM-120 (lysergide D-tartrate), which is currently in Phase 2 for generalized anxiety disorder.

    Product Name : Undisclosed

    Product Type : Controlled Substance

    Upfront Cash : Undisclosed

    August 03, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Harm Reduction Therapeutics and Catalent Sign Commercial Supply Agreement for Naloxone Nasal Spray to Reverse Opioid Overdoses

    Details:

    Under the agreement, Catalent will manufacture Harm Reduction Therapeutics’ naloxone nasal spray, RiVive™, for the emergency treatment of known or suspected opioid overdose.


    Lead Product(s): Naloxone Hydrochloride

    Therapeutic Area: Psychiatry/Psychology Brand Name: Rivive

    Study Phase: Phase IIIProduct Type: Controlled Substance

    Sponsor: Harm Reduction Therapeutics

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement March 23, 2023

    blank

    09

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Naloxone Hydrochloride

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Harm Reduction Therapeutics

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Harm Reduction Therapeutics and Catalent Sign Commercial Supply Agreement for Naloxone Nasal Spray...

    Details : Under the agreement, Catalent will manufacture Harm Reduction Therapeutics’ naloxone nasal spray, RiVive™, for the emergency treatment of known or suspected opioid overdose.

    Product Name : Rivive

    Product Type : Controlled Substance

    Upfront Cash : Undisclosed

    March 23, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Catalent and Grünenthal Announce Successful Collaboration to Facilitate Expedited Clinical Development Timelines

    Details:

    The collaboration leads to the successful reformulation of an investigational, orally dosed small molecule in Grünenthal’s pipeline to improve its bioavailability. Phase 1 studies of the molecule will be supported by using the Catalent Xpress Pharmaceutics™ platform.


    Lead Product(s): Undisclosed

    Therapeutic Area: Neurology Brand Name: Undisclosed

    Study Phase: PreclinicalProduct Type: Undisclosed

    Sponsor: Grunenthal

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Collaboration March 15, 2023

    blank

    10

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Catalent Pharma Solutions

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Neurology

    Highest Development Status : Preclinical

    Partner/Sponsor/Collaborator : Grunenthal

    Deal Size : Undisclosed

    Deal Type : Collaboration

    DEALS_DEV arrow-down

    Catalent and Grünenthal Announce Successful Collaboration to Facilitate Expedited Clinical Develo...

    Details : The collaboration leads to the successful reformulation of an investigational, orally dosed small molecule in Grünenthal’s pipeline to improve its bioavailability. Phase 1 studies of the molecule will be supported by using the Catalent Xpress Pharmace...

    Product Name : Undisclosed

    Product Type : Undisclosed

    Upfront Cash : Undisclosed

    March 15, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    Analytical

    Click here to discover the service providers for Analytical

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    Sales, Marketing, Registration

    Click here to discover the service providers for Sales, Marketing, Registration

    Clinical Trials

    Click here to discover the service providers for Clinical Trials

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Packaging

    Click here to discover the service providers for Packaging

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    THIRD-PARTY AUDIT

    read-more
    read-more

    01

    Eurofins Assurance

    Belgium
    arrow
    Get Site Audit
    CPhI Milan
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEurofins Assurance: Ensuring compliance, quality, and safety with expert inspection and certification.

    Catalent

    Country : Italy

    City/Region : Aprilia

    Audit Date : 2026-07-07

    Audit Type : On-Site

    Eurofins Assurance

    02

    Eurofins Assurance

    Belgium
    arrow
    Get Site Audit
    CPhI Milan
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEurofins Assurance: Ensuring compliance, quality, and safety with expert inspection and certification.

    Catalent

    Country : Argentina

    City/Region : Buenos Aires

    Audit Date : 2025-07-08

    Audit Type : On-Site

    Eurofins Assurance

    03

    Eurofins Assurance

    Belgium
    arrow
    Get Site Audit
    CPhI Milan
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEurofins Assurance: Ensuring compliance, quality, and safety with expert inspection and certification.

    Catalent

    Country : Italy

    City/Region : Aprilia

    Audit Date : 2023-12-12

    Audit Type : On-Site

    Eurofins Assurance

    04

    Eurofins Assurance

    Belgium
    arrow
    Get Site Audit
    CPhI Milan
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEurofins Assurance: Ensuring compliance, quality, and safety with expert inspection and certification.

    Catalent Pharma Solutions

    Country : U.S.A

    City/Region : Winchester

    Audit Date : 2023-09-12

    Audit Type : On-Site

    Eurofins Assurance

    05

    Eurofins Assurance

    Belgium
    arrow
    Get Site Audit
    CPhI Milan
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEurofins Assurance: Ensuring compliance, quality, and safety with expert inspection and certification.

    Catalent

    Country : Germany

    City/Region : Schorndorf

    Audit Date : 2023-07-25

    Audit Type : On-Site

    Eurofins Assurance

    06

    Eurofins Assurance

    Belgium
    arrow
    Get Site Audit
    CPhI Milan
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEurofins Assurance: Ensuring compliance, quality, and safety with expert inspection and certification.

    Catalent

    Country : Italy

    City/Region : Aprilia

    Audit Date : 2023-03-07

    Audit Type : On-Site

    Eurofins Assurance
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Catalent Pharma Solutions and get a quotation

    Catalent Pharma Solutions is a supplier offers 111 products (APIs, Excipients or Intermediates).

    Find a price of Hyaluronidase bulk with JDMF offered by Catalent Pharma Solutions

    Find a price of Netarsudil Mesylate bulk with JDMF offered by Catalent Pharma Solutions

    Find a price of Selegiline Hydrochloride bulk with DMF offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET - 10275485] bulk with DMF offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10275378] bulk with DMF offered by Catalent Pharma Solutions

    Find a price of Amprenavir bulk offered by Catalent Pharma Solutions

    Find a price of Atrasentan bulk offered by Catalent Pharma Solutions

    Find a price of Benzonatate bulk offered by Catalent Pharma Solutions

    Find a price of Bexarotene bulk offered by Catalent Pharma Solutions

    Find a price of Calcifediol bulk offered by Catalent Pharma Solutions

    Find a price of Calcitriol bulk offered by Catalent Pharma Solutions

    Find a price of Cyclosporine bulk offered by Catalent Pharma Solutions

    Find a price of Doxcercalciferol bulk offered by Catalent Pharma Solutions

    Find a price of Dutasteride bulk offered by Catalent Pharma Solutions

    Find a price of Enzalutamide bulk offered by Catalent Pharma Solutions

    Find a price of Estradiol bulk offered by Catalent Pharma Solutions

    Find a price of Ethosuximide bulk offered by Catalent Pharma Solutions

    Find a price of Ibuprofen bulk offered by Catalent Pharma Solutions

    Find a price of Icosapent Ethyl bulk offered by Catalent Pharma Solutions

    Find a price of Isotretinoin bulk offered by Catalent Pharma Solutions

    Find a price of Lopinavir bulk offered by Catalent Pharma Solutions

    Find a price of Loratadine bulk offered by Catalent Pharma Solutions

    Find a price of Lubiprostone bulk offered by Catalent Pharma Solutions

    Find a price of Miconazole bulk offered by Catalent Pharma Solutions

    Find a price of Miconazole Nitrate bulk offered by Catalent Pharma Solutions

    Find a price of Nifedipine bulk offered by Catalent Pharma Solutions

    Find a price of Nimodipine bulk offered by Catalent Pharma Solutions

    Find a price of Omega-3-Acid Ethyl Esters 90 bulk offered by Catalent Pharma Solutions

    Find a price of Palonosetron bulk offered by Catalent Pharma Solutions

    Find a price of Paricalcitol bulk offered by Catalent Pharma Solutions

    Find a price of Progesterone bulk offered by Catalent Pharma Solutions

    Find a price of Risperidone bulk offered by Catalent Pharma Solutions

    Find a price of Ritonavir bulk offered by Catalent Pharma Solutions

    Find a price of talarozole bulk offered by Catalent Pharma Solutions

    Find a price of Terazosin HCl bulk offered by Catalent Pharma Solutions

    Find a price of Tetrahydrocannabinol bulk offered by Catalent Pharma Solutions

    Find a price of Tipranavir bulk offered by Catalent Pharma Solutions

    Find a price of Tretinoin bulk offered by Catalent Pharma Solutions

    Find a price of Vitamin D bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10275226] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10275282] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10275260] bulk offered by Catalent Pharma Solutions

    Find a price of MICRONIZATION PROCESS FACILITY bulk offered by Catalent Pharma Solutions

    Find a price of CONTRACT MICRONIZATION FACILITY IN KENT, UNITED KINGDOM bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET 10275449 50] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10259015-17] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10259014] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10275198] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10275265] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10275266] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10275261] bulk offered by Catalent Pharma Solutions

    Find a price of WC3042-05, CAPSULE bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [0775279] bulk offered by Catalent Pharma Solutions

    Find a price of LANOXICAPS (0.5, 0.10, AND 0.20MG) SOFTGEL CAPSULES bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET - 10258984] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10275412] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET- 10275405-7] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10275268] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-00775174] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGEL CAPSULE [OET-10275263] bulk offered by Catalent Pharma Solutions

    Find a price of WC3042-08P CAPSULE bulk offered by Catalent Pharma Solutions

    Find a price of CONTRACT MICRONIZATION FACILITY IN EXTON, PA. bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10275547-9] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET: 10275427-9] bulk offered by Catalent Pharma Solutions

    Find a price of YXSORALEN-ULTRA SOFT GELATIN CAPSULES bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10258867] bulk offered by Catalent Pharma Solutions

    Find a price of SOFTGELS [OET-10275191] bulk offered by Catalent Pharma Solutions

    Find a price of Abiraterone Acetate bulk offered by Catalent Pharma Solutions

    Find a price of Acyclovir bulk offered by Catalent Pharma Solutions

    Find a price of Alectinib Hydrochloride bulk offered by Catalent Pharma Solutions

    Find a price of Amifampridine Phosphate bulk offered by Catalent Pharma Solutions

    Find a price of Anastrozole bulk offered by Catalent Pharma Solutions

    Find a price of Apixaban bulk offered by Catalent Pharma Solutions

    Find a price of Atazanavir Sulfate bulk offered by Catalent Pharma Solutions

    Find a price of Belumosudil bulk offered by Catalent Pharma Solutions

    Find a price of Bendroflumethiazide bulk offered by Catalent Pharma Solutions

    Find a price of Caffeine bulk offered by Catalent Pharma Solutions

    Find a price of Clonidine bulk offered by Catalent Pharma Solutions

    Find a price of Doxycycline bulk offered by Catalent Pharma Solutions

    Find a price of Efavirenz bulk offered by Catalent Pharma Solutions

    Find a price of Erythromycin bulk offered by Catalent Pharma Solutions

    Find a price of Exemestane bulk offered by Catalent Pharma Solutions

    Find a price of Felbamate bulk offered by Catalent Pharma Solutions

    Find a price of Fentanyl bulk offered by Catalent Pharma Solutions

    Find a price of Fluorouracil bulk offered by Catalent Pharma Solutions

    Find a price of Gentamicin Sulfate bulk offered by Catalent Pharma Solutions

    Find a price of Glucagon bulk offered by Catalent Pharma Solutions

    Find a price of Ibrutinib bulk offered by Catalent Pharma Solutions

    Find a price of Imetelstat bulk offered by Catalent Pharma Solutions

    Find a price of Isradipine bulk offered by Catalent Pharma Solutions

    Find a price of Letrozole bulk offered by Catalent Pharma Solutions

    Find a price of Levalbuterol Tartrate bulk offered by Catalent Pharma Solutions

    Find a price of Mavacamten bulk offered by Catalent Pharma Solutions

    Find a price of Morphine Sulfate bulk offered by Catalent Pharma Solutions

    Find a price of Neomycin Sulfate bulk offered by Catalent Pharma Solutions

    Find a price of Nepafenac bulk offered by Catalent Pharma Solutions

    Find a price of Olmesartan Medoxomil bulk offered by Catalent Pharma Solutions

    Find a price of Oxycodone Hydrochloride bulk offered by Catalent Pharma Solutions

    Find a price of Palovarotene bulk offered by Catalent Pharma Solutions

    Find a price of Paracetamol bulk offered by Catalent Pharma Solutions

    Find a price of Phenoxybenzamine HCl bulk offered by Catalent Pharma Solutions

    Find a price of Pilocarpine Hydrochloride bulk offered by Catalent Pharma Solutions

    Find a price of Promethazine Hydrochloride bulk offered by Catalent Pharma Solutions

    Find a price of Resmetirom bulk offered by Catalent Pharma Solutions

    Find a price of Rimegepant Sulfate bulk offered by Catalent Pharma Solutions

    Find a price of Salbutamol Sulphate bulk offered by Catalent Pharma Solutions

    Find a price of Secnidazole bulk offered by Catalent Pharma Solutions

    Find a price of Tafamidis bulk offered by Catalent Pharma Solutions

    Find a price of VANDETANIB bulk offered by Catalent Pharma Solutions

    Find a price of Zuranolone bulk offered by Catalent Pharma Solutions

    Find a price of ANSUVIMAB bulk offered by Catalent Pharma Solutions

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search